Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MELISSA C KANDER

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1174051809
CMS profile
3950424
Location
COLUMBUS, OH

General Payments · PY2020–2024

$496.78

  • Reported across 29 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$273.97

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $273.97 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $79.47 4
PFIZER INC. $59.45 3
Acerta Pharma LLC $58.75 4
GlaxoSmithKline, LLC. $35.54 2
Exact Sciences Corporation $21.97 1
NOVARTIS PHARMACEUTICALS CORPORATION $18.79 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $37.48 2
PY2021 $12.90 1
PY2022 $70.90 5
PY2023 $101.53 6
PY2024 $273.97 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $13.39 01/18/2024 Food and Beverage Undisputed 01/23/2026 1105756009 CMS
AstraZeneca Pharmaceuticals LP $15.19 04/14/2024 Food and Beverage Undisputed 01/23/2026 1104496018 CMS
AstraZeneca Pharmaceuticals LP $14.54 06/05/2024 Food and Beverage Undisputed 01/23/2026 1105902322 CMS
AstraZeneca Pharmaceuticals LP $15.63 09/25/2024 Food and Beverage Undisputed 01/23/2026 1105657206 CMS
Exact Sciences Corporation $21.97 03/26/2024 Food and Beverage Undisputed 01/23/2026 1114433473 CMS
GlaxoSmithKline, LLC. $17.81 02/27/2024 Food and Beverage Undisputed 01/23/2026 1116274067 CMS
GlaxoSmithKline, LLC. $17.73 09/19/2024 Food and Beverage Undisputed 01/23/2026 1116130298 CMS
Lilly USA, LLC $16.36 02/22/2024 Food and Beverage Undisputed 01/23/2026 1135189141 CMS
Lilly USA, LLC $17.80 05/08/2024 Food and Beverage Undisputed 01/23/2026 1135171374 CMS
Lilly USA, LLC $19.20 06/11/2024 Food and Beverage Undisputed 01/23/2026 1135188717 CMS
Lilly USA, LLC $26.11 07/25/2024 Food and Beverage Undisputed 01/23/2026 1135221769 CMS
Novartis Pharmaceuticals Corporation $18.79 12/18/2024 Food and Beverage Undisputed 01/23/2026 1087155782 CMS
PFIZER INC. $17.50 02/08/2024 Food and Beverage Undisputed 01/23/2026 1131157017 CMS
PFIZER INC. $21.41 04/25/2024 Food and Beverage Undisputed 01/23/2026 1131434426 CMS
PFIZER INC. $20.54 08/22/2024 Food and Beverage Undisputed 01/23/2026 1131882804 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.